“…Thus, a direct application of the satRNA technology was developed in transgenic tomato plants as a protection strategy against CMV. When the same plants were challenged with Tomato aspermy virus, another cucumovirus, they showed satRNA replication but neither helper virus downregulation nor significant tolerance to virus-induced symptoms (McGarvey, Montasser, & Kaper, 1994). Quantitative assays showed that replication of transcript satRNA induced a 10-fold decrease in CMV accumulation in the transgenic tomato plants compared to controls.…”